[go: up one dir, main page]

MX2015016765A - Celulas aviares para la produccion mejorada de virus. - Google Patents

Celulas aviares para la produccion mejorada de virus.

Info

Publication number
MX2015016765A
MX2015016765A MX2015016765A MX2015016765A MX2015016765A MX 2015016765 A MX2015016765 A MX 2015016765A MX 2015016765 A MX2015016765 A MX 2015016765A MX 2015016765 A MX2015016765 A MX 2015016765A MX 2015016765 A MX2015016765 A MX 2015016765A
Authority
MX
Mexico
Prior art keywords
seq
chicken
virus production
improved virus
cells
Prior art date
Application number
MX2015016765A
Other languages
English (en)
Other versions
MX366836B (es
Inventor
Fife Mark
Gibson Mark
Original Assignee
The Pirbright Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Pirbright Inst filed Critical The Pirbright Inst
Publication of MX2015016765A publication Critical patent/MX2015016765A/es
Publication of MX366836B publication Critical patent/MX366836B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)

Abstract

La presente invención proporciona una célula aviar en la cual la expresión o la actividad de uno o más de los siguientes genes, o un homólogo de los mismos: IFITM1 de Pollo (SEQ ID No. 1); IFITM2 de Pollo (SEQ ID No. 2) e IFITM3 de Pollo (SEQ ID No. 3) es reducida. La invención también proporciona los métodos para realizar pases de los virus en células de ave, embriones y/o líneas de células de ave que tienen expresión reducida de uno o más genes IFITM, y los métodos que involucran la investigación de la secuencia de uno o más de los siguientes genes, o un homólogo de los mismos: IFITM1 de Pollo (SEQ ID No. 1); IFITM2 de Pollo (SEQ ID No. 2) e IFITM3 de Pollo (SEQ ID No. 3).
MX2015016765A 2013-06-05 2014-06-03 Celulas aviares para la produccion mejorada de virus. MX366836B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1310031.8A GB201310031D0 (en) 2013-06-05 2013-06-05 Cell
PCT/GB2014/051693 WO2014195692A1 (en) 2013-06-05 2014-06-03 Avian cells for improved virus production

Publications (2)

Publication Number Publication Date
MX2015016765A true MX2015016765A (es) 2016-08-04
MX366836B MX366836B (es) 2019-07-26

Family

ID=48805789

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016765A MX366836B (es) 2013-06-05 2014-06-03 Celulas aviares para la produccion mejorada de virus.

Country Status (12)

Country Link
US (2) US10202578B2 (es)
EP (2) EP3004333B1 (es)
JP (1) JP6599316B2 (es)
KR (1) KR102277763B1 (es)
CN (2) CN105378073A (es)
AU (1) AU2014276631B2 (es)
CA (1) CA2914550C (es)
ES (1) ES2719952T3 (es)
GB (1) GB201310031D0 (es)
MX (1) MX366836B (es)
WO (1) WO2014195692A1 (es)
ZA (1) ZA201508828B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013204327B2 (en) * 2012-04-20 2016-09-01 Aviagen Cell transfection method
EP3380616A4 (en) * 2015-11-24 2019-11-06 Commonwealth Scientific and Industrial Research Organisation MANUFACTURE OF VIRUSES IN BIRDS
JP7189017B2 (ja) 2015-11-24 2022-12-13 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション 細胞培養におけるウイルスの生産
CN106434649B (zh) * 2016-07-18 2017-08-25 马国辅 一种抗禽传染性支气管炎病毒的肽核酸及应用
CN108085413B (zh) * 2017-12-06 2021-09-21 南京农业大学 一种用于同时检测三种禽病毒病的高通量试剂盒及其检测方法和应用
KR102520151B1 (ko) * 2020-09-11 2023-04-11 전북대학교산학협력단 닭의 ifitm3 단백질에 특이적으로 결합하는 단클론 항체 및 이의 용도
CN113527463B (zh) * 2021-08-20 2023-03-07 广西壮族自治区兽医研究所 Ifitm3蛋白相关物质在制备禽呼肠孤病毒所致疾病药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9804283B1 (pt) * 1998-03-18 2010-11-30 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.
CA2880060C (en) * 2004-01-23 2018-03-13 Agostino Cirillo Chimpanzee adenovirus vaccine carriers
BRPI0517742A (pt) * 2004-11-11 2008-10-21 Solvay Pharm Bv método para obter uma partìcula do vìrus da influenza condicionalmente defeituosa, partìcula de vìrus da influenza, célula, composição, uso da mesma, método para gerar proteção imunológica contra infecção de um indivìduo com um vìrus da influenza, uso de uma partìcula, e, métodos para suprir um ácido nucleico que não codifica um peptìdeo da influenza, a uma célula e a um indivìduo
US20100138946A1 (en) 2008-08-14 2010-06-03 Origen Therapeutics Transgenic chickens with an inactivated endogenous gene locus
WO2010125656A1 (ja) * 2009-04-28 2010-11-04 株式会社カネカ 外来性rnaを発現する抗病性トランスジェニック鳥類
BRPI1007743A2 (pt) * 2009-05-12 2017-09-19 Transgene Sa Linhagens de célula aviária imortalizada, usos de uma linhagem de célula aviária imortalizada, métodos para a produção de vírus e métodos para a produção de proteína
GB0911794D0 (en) * 2009-07-07 2009-08-19 Animal Health Inst Chimaeric protein
WO2011072247A2 (en) * 2009-12-11 2011-06-16 The Brigham And Women's Hospital, Inc. Pathogen restriction factors
CN102178927A (zh) * 2011-03-01 2011-09-14 中国人民解放军军事医学科学院放射与辐射医学研究所 干扰素诱导跨膜蛋白3在制备抗乙型肝炎病毒感染药物中的用途
WO2012158985A2 (en) 2011-05-17 2012-11-22 Transposagen Biopharmaceuticals, Inc. Methods for site-specific genetic modification in spermatogonial stem cells using zinc finger nuclease (zfn) for the creation of model organisms
CN102286465B (zh) * 2011-07-08 2012-10-17 华中农业大学 一种抑制口蹄疫病毒增殖的猪ifitm3基因及构建方法和应用

Also Published As

Publication number Publication date
CN110066769A (zh) 2019-07-30
EP3530733A1 (en) 2019-08-28
EP3004333A1 (en) 2016-04-13
JP6599316B2 (ja) 2019-10-30
AU2014276631A1 (en) 2015-12-24
GB201310031D0 (en) 2013-07-17
KR20160012240A (ko) 2016-02-02
CA2914550A1 (en) 2014-12-11
JP2016528878A (ja) 2016-09-23
CN110066769B (zh) 2024-03-08
ES2719952T3 (es) 2019-07-17
EP3004333B1 (en) 2019-01-16
US20190203170A1 (en) 2019-07-04
KR102277763B1 (ko) 2021-07-16
CN105378073A (zh) 2016-03-02
CA2914550C (en) 2024-09-10
BR112015030419A2 (pt) 2018-03-27
US20160108359A1 (en) 2016-04-21
WO2014195692A1 (en) 2014-12-11
MX366836B (es) 2019-07-26
AU2014276631B2 (en) 2020-06-25
US10202578B2 (en) 2019-02-12
ZA201508828B (en) 2019-04-24

Similar Documents

Publication Publication Date Title
MX2015016765A (es) Celulas aviares para la produccion mejorada de virus.
MX373660B (es) Fibroblastos de embrion de pollo inmortalizados.
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
EA201692535A1 (ru) Замещенные нуклеозиды, нуклеотиды и их аналоги
MX383531B (es) Novedoso bacteriófago clo-pep-1 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens
BR112018011881A2 (pt) proteínas capsidiais modificadas para liberação aumentada de vetores de parvovírus
EP4349404A3 (en) Respiratory virus vaccines
CL2016003277A1 (es) Métodos para preparar análogos de nucleótido sustituidos
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
MX387421B (es) Producción de virus en huevos aviares.
TR201818825T4 (tr) Kardi̇yak hi̇pertrofi̇ni̇n tedavi̇si̇ne ve tanisina yöneli̇k lncrnalar
CR20160195A (es) Composiciones y métodos para inhibir la expresión del gen alas 1
BR112015024119A2 (pt) polipeptídeos tendo atividade de fosfolipase a e polinucleotídeos que os codificam
MX387420B (es) Producción de virus en cultivos celulares.
MX373329B (es) Células eucariotas novedosas y métodos para la expresión recombinante de un producto de interés.
MX2016013308A (es) Uso de oxotetrahidroquinolinilsulfonamidas sustituidas o sus sales para aumentar la tolerancia al estres en plantas.
BR112017013453A2 (pt) novo peptídeo inibidor de pi3ky para o tratamento de doenças do sistema respiratório
MX2021013879A (es) Variantes de lipasa y polinucleotidos que las codifican.
BR112017008702A2 (pt) ?mutante de endoxilanase, dna, vetor, célula, método de produção de mutantes de endoxilanase, composição enzimática e método de produção de solução de açúcar?
EA201790296A1 (ru) Вакцина в виде рекомбинантного вектора на основе птичьего аденовируса серотипа 9
MX388393B (es) Plantas de tomate que permiten el establecimiento de los acaros.
MX381255B (es) Vacunas contra el reovirus aviar.
BR112015021772A2 (pt) método para a preparação de células embrionárias aviárias, método melhorado para a preparação de células embrionárias aviárias a partir de um embrião, cultura ou composição de células embrionárias aviárias, método para a produção ou amplificação de um vírus, e, composição de vacina
WO2015048523A3 (en) Mutant chondroitinase abc i compositions and methods of their use
MX380693B (es) Produccion de manool.

Legal Events

Date Code Title Description
FG Grant or registration